Cystatins 9 and C as a Novel Immunotherapy Treatment That Protects against Multidrug-Resistant New Delhi Metallo-Beta-Lactamase-1-Producing Klebsiella pneumoniae

Multidrug-resistant (MDR) bacterial pneumonia can induce dysregulated pulmonary and systemic inflammation leading to morbidity and mortality. Antibiotics to treat MDR pathogens do not function to modulate the extent and intensity of inflammation and can have serious side effects. Here we evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Holloway, Alex J., Yu, JiehJuen, Arulanandam, Bernard P., Hoskinson, Sarah M., Eaves-Pyles, Tonyia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826106/
https://www.ncbi.nlm.nih.gov/pubmed/29229643
http://dx.doi.org/10.1128/AAC.01900-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826106/
https://www.ncbi.nlm.nih.gov/pubmed/29229643
http://dx.doi.org/10.1128/AAC.01900-17

Ejemplares similares